PFWA
LOGC

Paces Ferry Wealth Advisors’s LogicBio Therapeutics, Inc. Common Stock LOGC Stock Holding History

Paces Ferry Wealth Advisors’s Portfolio LOGC Stock Details LOGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-150
Closed -$1K – 1224
2020
Q3 		$1K Buy
+150
New +$1.14K ﹤0.01% 1040

Other funds holding LOGC

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Paces Ferry Wealth Advisors's LOGC Position: Q4 2020 in Review

Paces Ferry Wealth Advisors sold out of LogicBio Therapeutics, Inc. Common Stock (LOGC) in Q4 2020, closing a stake of 150 shares — an estimated $1K sold.

Paces Ferry Wealth Advisors first reported a position in LOGC in Q3 2020 and held it in 1 quarter. The position peaked at $1K in Q3 2020. 59 funds tracked by Wall St. Rank hold LOGC as of Q4 2020.

  • Paces Ferry Wealth Advisors reported no remaining LogicBio Therapeutics, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Paces Ferry Wealth Advisors sold 150 LogicBio Therapeutics, Inc. Common Stock shares in Q4 2020, an estimated $1K.
  • Paces Ferry Wealth Advisors first reported a position in LogicBio Therapeutics, Inc. Common Stock in Q3 2020 and held it in 1 quarter.
  • Paces Ferry Wealth Advisors's LogicBio Therapeutics, Inc. Common Stock position peaked at $1K in Q3 2020.
  • 59 funds tracked by Wall St. Rank held LogicBio Therapeutics, Inc. Common Stock as of Q4 2020.

Based on Paces Ferry Wealth Advisors's 13F filing for Q4 2020, filed 5 Mar 2021.